Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Targeted cancer therapies often cause serious skin problems that need careful management.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Terbinafine quickly builds up in skin and hair, staying effective for over 3 weeks.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Alopecia areata treatment varies, with no optimal method established yet.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.